Caricamento quotazioni...
Previsioni
Il prezzo obiettivo medio degli analisti è 3,01€ (+155,08%). La mediana è 3,01€ (+155,08%).
| Acquista |
1 |
| Mantieni |
5 |
| Vendi |
0 |
Notizie Vai al feed delle notizie
SNDL reports weaker Q2 as Jeeter ramp-up pressures margins and Parallel U.S. deal advances
SNDL reported Q2 revenue of C$235.8 million, down 3.7% year over year, and gross profit declined 16.6% to C$56.3 million as liquor and cannabis demand softened and production ramp-up costs for Jeeter weighed on margins. The company recorded an operating loss, but generated positive operating cash flow trends, held C$183.2 million of unrestricted cash with no debt, and repurchased 11.7 million shares for C$23.3 million. Management expects profit initiatives to deliver over C$20 million of incremental operating income and forecasts full-year positive free cash flow. SNDL also advanced a restructuring to gain direct control of Parallel's medical cannabis operations in Florida, Texas and Massachusetts, potentially adding 56 stores and about C$150 million of annualized revenue pending approvals. » Altro su finance.yahoo.com
SNDL completes acquisition of cannabis assets from Parallel
SNDL has completed the purchase of certain assets from Surterra Holdings/Parallel and, through its joint venture Sunstream Bancorp, acquired an indirect majority economic interest in TransactionCo (66.7% equity, 69.4% of the debt). The acquisition includes 56 retail locations and three cultivation and production facilities in Florida, Texas and Massachusetts with annualized revenue of about $150 million; Parallel’s liabilities of roughly $842 million were extinguished. SNDL plans, subject to legal, regulatory, accounting and NASDAQ requirements, to convert the indirect interest into direct, consolidated holdings, but expects that adult‑use assets could remain partially deconsolidated. The transaction has no immediate impact on SNDL’s financial reporting, other than the acquisition of a loan position with a face value of $29.75 million purchased at a 25% discount. » Altro su de.investing.com
SNDL: takeover of 27 Ontario stores fails due to missing approvals
SNDL announced that the second closing for the purchase of 27 cannabis specialty stores in Ontario from 1CM will not occur because regulatory approvals were delayed and not received before the May 31, 2026 deadline. The previously completed acquisition of five stores in Alberta and Saskatchewan remains unaffected. SNDL plans to redirect the capital intended for Ontario into its share buyback program; the program permits repurchases of up to USD 100 million, and to date over 5.5 million shares have been repurchased for about USD 11.1 million. Management stresses the strength of the retail platform, and financial metrics show high liquidity (current ratio 4.84) as well as an expected return to profitability this year. » Altro su de.investing.com
Dati finanziari dell'azienda
| (EUR) | giu 2026 | |
|---|---|---|
| Ricavi | 145,40M | 4,74% |
| Utile lordo | 34,75M | 17,56% |
| Utile netto | −4,82M | 368,15% |
| EBITDA | 4,08M | 64,88% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 308,55M€ |
Numero di azioni | 260,30M |
Massimo/minimo a 52 settimane | 2,48€ - 1,00€ |
| Dividendi | No |
Beta | 0,95 |
Rapporto P/E | −20,09 |
Rapporto PEG | 0,46 |
Rapporto P/B | 0,46 |
Rapporto P/S | 0,54 |
Profilo aziendale
Sundial Growers Inc. beschäftigt sich mit der Produktion, dem Vertrieb und dem Verkauf von Cannabisprodukten in Kanada. Das Unternehmen ist in den Segmenten Cannabis Operations und Retail Operations tätig. Es beschäftigt sich mit dem Anbau, dem Vertrieb und dem Verkauf von Cannabis für den Erwachsenenmarkt und dem privaten Verkauf von Cannabis für den Freizeitgebrauch durch unternehmenseigene und konzessionierte Cannabisgeschäfte. Das Unternehmen produziert und vertreibt auch inhalierbare Produkte, wie Blüten, Pre-Rolls und Vapes. Es bietet seine Produkte unter den Marken Top Leaf, Sundial Cannabis, Palmetto und Grasslands an. Sundial Growers Inc. wurde im Jahr 2006 gegründet und hat seinen Hauptsitz in Calgary, Kanada.
| Nome | Sundial Growers |
| CEO | Zachary Ryan George |
| Sede centrale | Edmonton,
ab Canada |
| Sito web | |
| Settore | Sanità |
| Industria | Biotecnologia |
| Quotazione in borsa | 01/08/2019 |
| Dipendenti | 2.751 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
NASDAQ | SNDL |
Düsseldorf | 14K.DU |
Frankfurt | 14K.F |
Hamburg | 14K.HM |
München | 14K.MU |
Scopri gli asset
Gli azionisti di Sundial Growers investono anche nei seguenti asset



